In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss a case that was recently overturned by the Supreme Court of the United States that may have ramifications for the healthcare industry, including impacts on regulatory oversight.

Their discussion includes:

• A summary of the Supreme Court ruling on June 28 to overturn the 1984 Chevron v. Natural Resources Defense Council decision, and how that impacts the power of federal agencies and the interpretations of the laws they administer.  
• How this decision may impact current healthcare issues like reimbursement and the U.S. Food and Drug Administration’s (FDA) final rule on regulating laboratory-developed tests as medical devices.
• The ambiguity of what comes next, and the importance of engaging members of Congress on these important decisions.